In breast cancer, IDH2 was reported to contribute to cell proliferation, anchorage-independent growth, glycolysis, mitochondrial respiration, and antioxidant defense [8], and be associated with an aggressive phenotype of breast carcinoma [10]. Here, IDH2 is linked to breast carcinoma.